The largest database of trusted experimental protocols

5 protocols using cd42a fitc

1

Platelet Activation Measurement by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Platelet activation was quantified by the upregulation of their surface markers, CD63 and CD62P, by flow cytometry. Briefly, after separation from whole blood, the platelet suspension was kept at 25°C for 4 hours, followed by re-calcification and incubation with E. coli for 15 minutes at 37°C. Then, platelets were stained for 30 minutes in the dark at 4°C with an antibody mixture containing platelet CD42a-FITC (catalog no. 348083, BD Biosciences, San Jose, CA), CD63-PE-Cy7 (catalog no. 25-0639-42, Invitrogen, Carlsbad, CA), and CD62P-PE (catalog no. 555524, BD Biosciences). After staining, the solution was centrifuged at 250×g, 4°C for 5 minutes. The supernatant was discarded and the pellet was resuspended and fixed in PBS containing 0.1% paraformaldehyde (PFA) and 0.1% bovine serum albumin (PBSA) and stored at 4°C until analysis with flow cytometer Attune NxT Acoustic Focusing Cytometer (Thermo Fisher Scientific) within 24 hours from sampling. Platelets were gated as CD42a+ population (Supplementary Figure 1) while CD63 and CD62P were used as platelet activation measures. Flow data analysis was performed with FlowJo software version 10 (Ashland, OR).
+ Open protocol
+ Expand
2

Monocyte-Platelet Aggregation and Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously described, 14 (link) monocyte platelet aggregation (MPA) was measured via whole blood flow cytometry using the Accuri 6 system. Immediately following phlebotomy, whole blood was fixed with formaldehyde in 1.4× Hanks balanced saline solution. Blood was labeled with monoclonal antibodies CD14-PE (BD Pharmingen) and CD42a-FITC (BD Pharmingen); diluted 4.6-fold with distilled water to lyse the erythrocytes; and further diluted in an equal volume of HEPES–Tyrode’s buffer, pH 7.4. Monocytes were identified by their staining with CD14-PE and by their characteristic orthogonal light scatter. The percentage of MPA was identified in single parameter histograms of CD42a-FITC fluorescence displaying events from the monocyte gate. The positive analysis region was determined using an IgG-FITC conjugated isotypic control. A minimum of 2,000 monocytes was counted per test.
Platelet activity was also assessed by activation of the platelet integrin αIIbβ3 activity using a FITC-conjugated PAC-1 antibody (BD Biosciences). Platelets were labeled with anti CD42b PE antibody (BD Biosciences). The mean fluorescent intensity (MFI) was assessed within a participant gated sample of approximately 10,000 platelets.
+ Open protocol
+ Expand
3

Platelet and Leukocyte Aggregation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of platelet surface P-selectin and leukocyte - platelet heterotypic aggregates were measured by flow cytometry (FC500 flow cytometer, Beckman Coulter). To standardize measurement conditions and to minimize in vitro platelet activation whole blood was fixed for P-selectin measurement and labelled for heterotypic aggregate determination within 2 h after blood collection. After fixation and washing by PBS, samples were labelled by CD42a-FITC and CD62-PE (Becton Dickinson Biosciences) for 20 min, washed twice and analyzed. Whole blood samples were incubated with CD14-PE and CD42a-FITC for 15 min to detect leukocyte-platelet heterotypic aggregates. Results were always compared to samples stained with non-immune IgG that served as isotype controls. Red blood cells were lysed and the samples were washed twice and fixed and subsequently analyzed.
+ Open protocol
+ Expand
4

Platelet Activation via P-selectin Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Investigation of platelet activation level via surface P-selectin expression on platelets was performed, as previously reported [26 (link)]. Briefly, 40 μL of whole blood samples were fixed in 1 mL 1% PFA and kept at RT for 1 h. Platelets were identified by a FITC-conjugated monoclonal antibody to GPIX (CD42a-FITC, Becton Dickinson, San Jose, CA, USA). Platelet activation was detected by phycoerythrin (PE)-labeled anti-P-selectin (CD62-PE, Becton Dickinson, San Jose, CA, USA). Fixed platelets were incubated with saturating concentrations of antibodies for 20 min in the dark at RT. As a control for immunolabeling with anti-CD62 antibody, platelets were incubated with PE-coupled non-immune mouse IgG1 antibody (Becton Dickinson, San Jose, CA, USA). A total of 10,000 dual-color labeled platelet events were acquired on an FC-500 flow cytometer (Beckman Coulter, Pasadena, CA, USA). Results were expressed as the percentage of double-positive platelets.
+ Open protocol
+ Expand
5

Platelet activation signaling pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dasatinib and nilotinib for in vitro experiments were from Cayman Chemical (Ann Arbor, MI, USA). The following directly conjugated monoclonal antibodies were purchased from Becton Dickinson (San Jose, CA, USA): annexin V-FITC, CD41a-PECy5, CD42a-FITC, CD62P-PE, PAC1-FITC. CD41-PE was from DAKO (Glostrup, Denmark). Dimethylsulfoxide (DMSO), Sepharose CL-2B, anti-actin and biotin conjugated anti-rabbit IgG were from Sigma-Aldrich (St. Louis, MO, USA) and convulxin were from Pentapharm (Basel, Switzerland). For western blot we used the following polyclonal antibodies: p-Fyn Y530, p-Lyn Y396, p-Src Y529, and p-Src Y418 (Thermo Fischer Scientific, Rockford, IL, USA); p-Fyn Y416 and p-Lyn Y507 Biorbyt (San Francisco, CA, USA); and Cell Signaling Technology (Leiden, The Netherlands), respectively. Avidin-biotin complex kit was from Vector Laboratories (Burlingame, CA, USA), and ECL reagent was used from Millipore (Billerica, MA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!